News Room

North Carolina COVID-19 hospitalizations hit a record high Tuesday for a fourth straight day. The numbers could continue to rise in coming weeks as the state sees the brunt of coronavirus spread from Christmas and other holiday gatherings, experts said. “Unfortunately, we’re seeing the very early stages of a post-holiday surge,” said Dr. Joseph Rogers, chief medical officer for Duke University Health System. “And I think many of us that are working in health systems across the Triangle are worried about what this ends up looking like.”

With more and more people in the United States getting vaccinated, many are worried that some will try to cut the line. More than 140,000 Massachusetts residents, mostly COVID-19 facing healthcare professionals, have already received their first dose, according to state officials. Public health statistics show that while the federal government has shipped 328,000 doses of the vaccine, only 44 percent have been administered. “Certainly we would like this vaccine to be going out more quickly,” Vaccine distribution expert and Carolina University Professor Julie Swann said.

Getting the COVID-19 vaccine into people's arms has proven to be a big stumbling block in North Carolina. Help is on the way, though, from many sources. The North Carolina National Guard has mobilized 50 members to help administer the vaccine and to help input data into the state's COVID-19 tracking system. "We increase our number of guardsmen on duty to help North Carolina get needles into arms with the immunization for those that are willing to take the vaccines," said Brig. Gen. Jeff Copeland.

Sarah Bowers has called fruitlessly around to multiple county and state officials to see if she could find any information on when her 95-year-old mother would be eligible for the vaccine. Bowers' mother resides in the independent living section of a senior facility in Indianapolis. Residents in the skilled nursing part of the campus have been vaccinated, but not Bowers' mother, who's in quarantine right now in her apartment.

Pharma companies are always talking about moving ‘beyond the pill’, and Pfizer’s new brand identity embodies that – it’s decades old pill-like logo has been replaced with a DNA double helix that it says reflects its commitment to breakthrough science. The logo – which retains the company’s traditional blue colour scheme – has been more than 18 months in the making and according to the company it is “unlocking the pill to reveal Pfizer’s DNA: the power of science.”